The ICD code D472 is used to code Monoclonal gammopathy of undetermined significance. Monoclonal gammopathy of undetermined significance (MGUS, unknown or uncertain may be substituted for undetermined), formerly benign monoclonal gammopathy, is a condition in which a paraprotein is found in the blood during standard laboratory blood tests.
A 'billable code' is detailed enough to be used to specify a medical diagnosis. Monoclonal gammopathy of undetermined significance (MGUS, unknown or uncertain may be substituted for undetermined), formerly benign monoclonal gammopathy, is a condition in which a paraprotein is found in the blood during standard laboratory blood tests.
D47.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM D47.2 became effective on October 1, 2020. This is the American ICD-10-CM version of D47.2 - other international versions of ICD-10 D47.2 may differ. All neoplasms are classified in this chapter, whether ...
Monoclonal gammopathy of undetermined significance (MGUS, unknown or uncertain may be substituted for undetermined), formerly benign monoclonal gammopathy, is a condition in which a paraprotein is found in the blood during standard laboratory blood tests.
ICD-10 code: D47. 2 Monoclonal gammopathy of undetermined significance (MGUS)
Monoclonal gammopathies are conditions in which abnormal proteins are found in the blood. These proteins grow from a small number of plasma cells in the bone marrow. Plasma cells are a type of white blood cell.
273.1 - Monoclonal paraproteinemia. ICD-10-CM.
Overview. Monoclonal gammopathy of undetermined significance (MGUS) is a condition in which an abnormal protein — known as monoclonal protein or M protein — is in your blood. This abnormal protein is formed within your bone marrow, the soft, blood-producing tissue that fills in the center of most of your bones.
Although people with multiple myeloma have a monoclonal gammopathy, not everyone with monoclonal gammopathy has multiple myeloma. It can also occur in other diseases, such as Waldenstrom macroglobulinemia and some lymphomas.
A gammopathy is an abnormal increase in immunoglobulin synthesis. Gammopathies that are monoclonal usually signify malignancy such as multiple myeloma, Waldenström's disease, heavy chains disease, or chronic lymphocytic leukemia.
Paraproteinemia, also known as monoclonal gammopathy, is characterized by the presence of excessive amounts of paraproteins in the blood. Paraproteins are immunoglobulin proteins that are produced by a clone of plasma cells in the bone marrow. These proteins often cause damage to the kidneys.
ICD-10 code: C90. 00 Multiple myeloma Without mention of complete remission.
A benign condition in which there is a higher-than-normal level of a protein called m protein in the blood. Patients with mgus are at an increased risk of developing cancer. A laboratory test result indicating the presence of an abnormally high level of monoclonal immunoglobulins in the blood or urine.
There are 3 subtypes of MGUS, namely, immunoglobulin M (IgM) MGUS, non-IgM MGUS, and light-chain MGUS, each with distinct rate and type of progression (Table 1).
Multiple myeloma is a type of blood cancer affecting the plasma cells. MGUS, a noncancerous condition also affecting the plasma cells, can sometimes precede it. Because multiple myeloma (MM) affects the production of healthy white blood cells, it affects the immune system.
M proteins are grouped by what kind of heavy and light chains they have. There are five kinds of heavy chains, called IgG, IgA, IgD, IgM, and IgE.
What causes monoclonal gammopathies? The exact cause of MGUS is not known. Infection, immune system problems, and the environment may play a role.
Treatment. MGUS doesn't require treatment. But your doctor is likely to recommend periodic checkups to monitor your health, probably starting six months after your diagnosis.
There's no way to treat MGUS. It doesn't go away on its own, but it doesn't usually cause symptoms or develop into a serious condition. A doctor will recommend regular checkups and blood tests to keep an eye on your health.
Data from the Mayo Clinic showed that the median survival of MGUS patients was 8.1 years compared to 11.8 in the comparable US population. In a prior study from Denmark, 1,324 MGUS patients were found to have a 2-fold higher mortality compared to that of the general population.
A plasma cell disorder in which an abnormal amount of a single immunoglobulin is present in the serum. Up to 25% of cases of monoclonal gammopathy of undetermined significance (mgus) progress to a b-cell malignancy or myeloma.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
Monoclonal gammopathy of undetermined significance (MGUS, unknown or uncertain may be substituted for undetermined), formerly benign monoclonal gammopathy, is a condition in which a paraprotein is found in the blood during standard laboratory blood tests.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
DRG Group #814-816 - Reticuloendothelial and immunity disorders with MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code D47.2. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code D47.2 and a single ICD9 code, 273.1 is an approximate match for comparison and conversion purposes.
D47.2 is a valid billable ICD-10 diagnosis code for Monoclonal gammopathy . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically. See also: